|کد مقاله||کد نشریه||سال انتشار||مقاله انگلیسی||ترجمه فارسی||نسخه تمام متن|
|5665897||1407776||2017||3 صفحه PDF||ندارد||دانلود رایگان|
â¢The in vitro synergy between ceftazidime, aztreonam, and ceftazidime-avibactam was assessed against 7 serine and metallo-Î²-lactamase producing pathogensâ¢Aztreonam and ceftazidime-avibactam were synergistic against metallo-Î²-lactamase-producing Enterobacteriaceae spp.â¢None of the combinations tested were consistently synergistic against IMP-producing Pseudomonas aeruginosa.â¢The Etest MIC:MIC ratio method may be clinically practical for assessing synergy.
This study assessed the in vitro synergy between ceftazidime, aztreonam, and ceftazidime-avibactam against serine and metallo-Î²-lactamase (MBL)-producing pathogens via the Etest MIC:MIC ratio and Agar-Etest synergy methods. The combination of aztreonam and ceftazidime-avibactam was synergistic against all Enterobacteriaceae. None of the tested combinations were consistently synergistic against IMP-producing P. aeruginosa.
Graphical abstractDownload high-res image (71KB)Download full-size image
Journal: Diagnostic Microbiology and Infectious Disease - Volume 88, Issue 4, August 2017, Pages 352-354